Technology
HemoBeads
HemoSystem
Congresses & Publications
Applications
Combination gene therapy
Sepsis therapy
Bioseparation & Processing
About us
Company
Team
Working at hemotune
Newsroom
Quality
Contact
Investors
Search
Menu
Home
Technology
HemoBeads
HemoSystem
Congresses & Publications
Applications
Combination gene therapy
Sepsis therapy
Bioseparation & Processing
About us
Company
Team
Working at hemotune
Newsroom
Quality
Contact
Investors
Your browser has JavaScript disabled. To use all features of this website, please enable JavaScript.
hemotune
About us
Newsroom
Newsroom
Launch of the Working Group on Sepsis and Cancer
hemotune AG appoints Harald Casebourne Stock as President of the Board of Directors
EN ISO 13485 Certification Expansion
hemotune raises CHF 14 million Series B2 funding for clinical trials with the HemoSystem
